Bleeding Disorders

Bleeding Disorders

A collection of features and news articles published in ASH Clinical News related to bleeding disorders.

Emicizumab-kxwh Approved by FDA for Patients With Hemophilia A and Inhibitors

The U.S. Food and Drug Administration approved the first-in-class emicizumab-kxwh for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adult...

Anticoagulation During Pregnancy

Because of physiologic changes during pregnancy, the risk of venous thromboembolism (VTE) is approximately five to 10 times higher than during non-pregnancy, and the...

Future Directions and Challenges in Treating Sickle Cell Disease: An Interview with Griffin Rodgers,...

Patients with sickle cell disease (SCD) face chronic and often debilitating complications, but have limited treatment options. Several presentations at this year’s ASH annual...

Grassroots Lobbying Efforts Lead to a Win for SCD Patients in Tennessee: An Interview...

Sickle cell disease (SCD) is the most common, inherited red blood cell disorder in the United States – affecting 70,000 to 100,000 Americans. Although...

The Road to the New Sickle Cell Disease Guidelines: Interview with Co-Chair George R....

On September 9, 2014, the National Heart, Lung, and Blood Institute (NHLBI) released an evidence-based expert panel report on the management of sickle cell...
Advertisement

Current Issue

August 2019, Volume 5, Issue 10

August 2019, Volume 5, Issue 10

This issue features a debate about gun control as a health care issue, a look at blood services in Israel and Palestine, and more.